Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
So far Saturday, July 18, NASDAQ is down -1.01% and the S&P is down -0.16%. Let’s take a look at
Dynavax Signs a Pact to Develop Universal Influenza Vaccine
03:42pm, Friday, 17'th Jul 2020
Dynavax (DVAX) inks a deal with Mount Sinai to develop a universal influenza vaccine candidate using its CpG 1018 adjuvant. The development is funded under a contract win from NIAID.
Why Dynavax's Stock Is Trading Higher Today
03:23pm, Friday, 17'th Jul 2020
Dynavax (NASDAQ: DVAX) shares are trading higher on Friday amid strength in vaccine stocks for the session. The company on Thursday announced a collaboration with Mount Sinai to develop a universal fl
MERIAN GLOBAL INVESTORS UK Ltd Invests $168,000 in Dynavax Technologies Co. (NASDAQ:DVAX)
09:36am, Friday, 17'th Jul 2020
MERIAN GLOBAL INVESTORS UK Ltd acquired a new position in shares of Dynavax Technologies Co. (NASDAQ:DVAX) during the second quarter, Holdings Channel reports. The institutional investor acquired 19,0
Dynavax Teams Up With Mt Sinai On Universal Flu Vaccine
09:29am, Friday, 17'th Jul 2020
Vaccine-focused biopharma Dynavax Technologies (DVAX) has announced a collaboration to develop a universal influenza (flu) vaccine with the Icahn School
Dynavax (DVAX) Gets a Buy Rating from H.C. Wainwright - Markets
04:07pm, Thursday, 16'th Jul 2020
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Dynavax (DVAX – Research Report),
Dynavax, Mount Sinai to work on universal flu vaccine
02:02pm, Thursday, 16'th Jul 2020
Shares of Dynavax Technologies Corp. undefined gained 0.2% in trading on Thursday after the company announced that it will work with the Icahn School of...
Dynavax, Mount Sinai to work on universal flu vaccine
02:02pm, Thursday, 16'th Jul 2020
Shares of Dynavax Technologies Corp. gained 0.2% in trading on Thursday after the company announced that it will work with the Icahn School of Medicine at the Mount Sinai hospital system in New York
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
12:40pm, Thursday, 16'th Jul 2020
Development funded under contract award from NIAID/NIH as part of the CIVICs programCurrently no approved universal influenza vaccineCDC estimates 35.5 million people were.
My COVID-19 Vaccine Report Card
09:41am, Thursday, 16'th Jul 2020
The COVID-19 pandemic has created a gold-rush on vaccine stocks. Many of the small-cap biotech and pharmaceutical companies have experienced 1000%+ gains as investors speculative who will be first.
Medicago comienza ensayos clínicos de fase I para su candidato a vacuna para la COVID-19
12:00am, Wednesday, 15'th Jul 2020
Medicago, una empresa biofarmacéutica con sede en la ciudad de Quebec, comenzó ayer ensayos clínicos de fase I para su candidato a vacuna para la COVI
Here's Why Dynavax Is Surging 6.1% Today | The Motley Fool
07:51pm, Tuesday, 14'th Jul 2020
Enrollment has begun in an early stage coronavirus vaccine trial utilizing Dynavax's technology.
Why Dynavax's Stock Is Trading Higher Today
03:28pm, Tuesday, 14'th Jul 2020
Dynavax Technologies (NASDAQ: DVAX) shares were trading higher on Tuesday after the company announced that the first participants were dosed with the company's coronavirus vaccine candidate the CpG 10
Canada's Medicago begins human trials of plant-based COVID-19 vaccine
12:00pm, Tuesday, 14'th Jul 2020
Medicago said on Tuesday it has begun testing its plant-based coronavirus vaccine in an early-stage clinical trial as the Canadian company, backed by tobacco company Phillip Morris, races against larg
* Medicago expects to enroll 180 healthy adult participants * Preliminary safety and immunogenicity results are expected in October 2020 * Dynavax is providing CpG 1018, the adjuvant contained in
